Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

The absolute number of COVID-19 deaths was three times higher than those from flu, but the case-fatality ratio was comparable ...

Australia's Therapeutic Goods Administration has approved a new COVID booster by Pfizer targeting the JN.1 sub-variant of Omicron. Despite evolving variants, boosters remain crucial, especially for ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Health officials say eligible residents can receive the COVID-19 vaccine at the same time as or at any time before or after ...

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

Pfizer and partner BioNTech have started their clinical trial of a new version of their COVID-19 vaccine that has been specifically designed to protect against the Omicron variant. The trial in ...

"At the height of the Omicron wave, we still saw a lot of children being hospitalized," Jennifer Nayak, MD, associate ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...